Mizuho Securities has lowered its price target on Tesla Inc. (NASDAQ: TSLA) to $325 from $375 after the EV giant reported disappointing Q1 results. Despite the downgrade, the brokerage maintained its "Outperform" rating, citing optimism around Tesla’s upcoming low-cost models and autonomous vehicle ambitions.
Tesla’s first-quarter earnings fell short on both top and bottom lines. The company posted earnings per share of $0.27, missing Wall Street’s estimate of $0.44. Revenue also came in below expectations at $19.3 billion versus the $21.4 billion consensus. Mizuho noted the underperformance was anticipated, yet still sees an 8% year-over-year decline in Tesla’s 2025 deliveries, following the firm’s withdrawal of its annual guidance.
However, Mizuho remains bullish on Tesla’s longer-term growth potential. Analysts highlighted the expected launch of a low-cost Model Y in the first half of 2025 and the rollout of Tesla’s autonomous Cybercab in early 2026 as key catalysts. Despite reports suggesting delays to 2026, Mizuho believes the Model Y launch is still on track, though production ramp-up may be slower than initially projected.
The brokerage emphasized Tesla’s continued leadership in the U.S. EV market, which could help cushion losses stemming from fierce competition and political backlash in China and parts of Europe.
Elon Musk, Tesla’s CEO, also pledged to shift focus back to the company by stepping back from his government-related duties starting in May—a move that sparked a rally in Tesla shares despite weak earnings.
With Tesla navigating challenges from global EV competition and political scrutiny, Mizuho sees its innovation pipeline as a critical driver of future growth.


TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Washington Post Publisher Will Lewis Steps Down After Layoffs
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Instagram Outage Disrupts Thousands of U.S. Users
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



